Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Intersect Ent Inc (NQ: XENT )

N/A UNCHANGED
Last Price Updated: 4:00 PM EDT, May 12, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Intersect Ent Inc

Benzinga's Top Ratings Upgrades, Downgrades For August 12, 2021
Upgrades According to Northland Capital Markets, the prior rating for Points International Ltd 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For August 9, 2021
Upgrades DA Davidson upgraded the previous rating for AAON Inc (NASDAQ: 
Via Benzinga
Earnings Scheduled For May 10, 2021
Companies Reporting Before The Bell • Revlon (NYSE:REV) is likely to report earnings for its first quarter. • Bluegreen Vacations (NYSE:BVH) is expected to report... 
Via Benzinga
The Daily Biotech Pulse: FDA Rejects FibroGen's Anemia Drug, Crinetics Gains On Positive Readout, BioCryst Withdraws Public Offering
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 10) Alnylam Pharmaceuticals,... 
Via Benzinga
Exposures Product Safety
The Daily Biotech Pulse: Arcturus Soars On COVID-19 Vaccine Updates, Merck's Keytruda On Track For More Label Expansions, Eliem Debuts
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 9) Adagio Therapeutics, Inc. (... 
Via Benzinga
Exposures COVID-19
Why Intersect ENT Shot 12% Higher on Friday
It's official: A big peer is buying out the specialty medical device maker. 
Via The Motley Fool
12 Health Care Stocks Moving In Friday's Intraday Session
Gainers SCWorx (NASDAQ:WORX) shares moved upwards by 20.59% to $3.08 during Friday's regular session. The current volume of 16.2 million shares is 348.19% of SCWorx... 
Via Benzinga
Medtronic Expands Its ENT Portfolio With Intersect ENT Acquisition For $28.25/Share
Medtronic plc (NYSE:MDT) 
Via Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
Gainers Applied Molecular (NASDAQ:AMTI) shares increased by 19.38% to $35.54 during Friday's pre-market session. The market value of their outstanding shares is at $1.... 
Via Benzinga
Intersect ENT: Q2 Earnings Insights
Shares of Intersect ENT (NASDAQ:XENT) remained unaffected after the company reported Q2 results. Quarterly Results Earnings per share increased 24.62% year over year to ($0... 
Via Benzinga
Earnings Scheduled For August 6, 2021
Companies Reporting Before The Bell • Liberty Braves Group (NASDAQ:BATRA) is projected to report quarterly loss at $0.03 per share on revenue of $154.00 million.... 
Via Benzinga
Intersect ENT Sees Q2 Sales Lag Wall Street Estimates; Raises $60M In Debt Funding
Intersect ENT Inc (NASDAQ: XENT) expects Q2 sales of approximately $27.3 million, slightly below the consensus estimate of $28.02 million. Record quarterly revenue from... 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For June 24, 2021
Upgrades Zelman upgraded the previous rating for Armstrong World Industries Inc (NYSE: 
Via Benzinga
Intersect ENT Insights: Return On Capital Employed
In Q1, Intersect ENT (NASDAQ:XENT) posted sales of $24.33 million. Earnings were up 7.66%, but Intersect ENT still reported an overall loss of $18.57 million. Intersect ENT... 
Via Benzinga
Intersect ENT Insights: Return On Capital Employed
In Q1, Intersect ENT (NASDAQ:XENT) posted sales of $24.33 million. Earnings were up 7.66%, but Intersect ENT still reported an overall loss of $18.57 million. In Q4, Intersect ENT... 
Via Benzinga
Recap: Intersect ENT Q1 Earnings
Shares of Intersect ENT (NASDAQ:XENT) remained unaffected after the company reported Q1 results. Quarterly Results Earnings per share rose 5.56% year over year to ($0.51),... 
Via Benzinga
The Week Ahead In Biotech (May 9-15): Heron, Apellis FDA Decisions, Presentations and Earnings
Biotech stocks came under pressure in the week ended May 7 as traders digested a slew of earnings news flow and a handful of clinical trial readouts. COVID-19 vaccine stocks came... 
Via Benzinga
Exposures COVID-19 Product Safety
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.